Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Anita Chudecka"'
Autor:
Anna Jagodzińska, Anita Chudecka-Głaz, Kaja Michalczyk, Ewa Pius-Sadowska, Sylwia Wieder-Huszla, Anna Jurczak, Bogusław Machaliński
Publikováno v:
Diagnostics, Vol 13, Iss 3, p 399 (2023)
Endometrial cancer is becoming an increasing problem. Taking into account its pathomechanisms, we aimed to investigate whether FGF 21, an important metabolism regulator, could be used as a biomarker for endometrial cancer. The study included 233 pati
Externí odkaz:
https://doaj.org/article/be5caab9b2d14cabb610de8c1115357b
Autor:
Anita Chudecka-Głaz, Aleksandra Strojna, Kaja Michalczyk, Sylwia Wieder-Huszla, Krzysztof Safranow, Edyta Skwirczyńska, Anna Jurczak
Publikováno v:
Diagnostics, Vol 13, Iss 3, p 452 (2023)
HE4 is a commonly used tumor marker for ovarian cancer (OC) diagnosis. In our study, we aimed to assess its use in the diagnosis of subsequent OC recurrences and to evaluate its changes during recurrence diagnosis and the subsequent lines of chemothe
Externí odkaz:
https://doaj.org/article/59df127cc98c41ce8a7168b1c3d3cb2e
Autor:
Janusz Menkiszak, Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, Aleksander Celewicz, Zbigniew Kojs, Mariusz Szajda, Maria Świniarska, Ryszard Bedner, Anna Jurczak, Marta Celewicz, Monika Cieszyńska, Jan Lubiński, Jacek Gronwald
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 17, Iss 1, Pp 1-5 (2019)
Abstract Background Since more than two decades Risk-reducing salpingo-oophorectomy (RRSO) is recommended and widely accepted by BRCA1/2 carriers as a method reducing ovarian cancer risk and improving survival rate. After RRSO, there remains a risk o
Externí odkaz:
https://doaj.org/article/50ca9ca7ca9141169059d841e82b1b13
Autor:
Sylwia Wieder-Huszla, Anita Chudecka-Głaz, Aneta Cymbaluk-Płoska, Beata Karakiewicz, Mateusz Bosiacki, Dariusz Chlubek, Anna Jurczak
Publikováno v:
Nutrients, Vol 14, Iss 12, p 2368 (2022)
(1) Background: The aim of this study was to assess the concentrations of selected elements in female patients with cancer of the reproductive organs, taking into account the stage of treatment. (2) Methods: The study sample consisted of 51 patients
Externí odkaz:
https://doaj.org/article/302588b631b54895bfc4b386c00aec49
Autor:
Aneta Cymbaluk-Płoska, Anita Chudecka-Głaz, Ewa Pius-Sadowska, Bogusław Machaliński, Janusz Menkiszak, Agnieszka Sompolska-Rzechuła
Publikováno v:
Journal of Ovarian Research, Vol 11, Iss 1, Pp 1-9 (2018)
Abstract Background MMP and TIMP play an important role in the degradation of extracellular matrix components which are essential for tumor growth, invasion and metastasis. Aim of this research was to assess MMP3 and TIMP3 as prognostic factors among
Externí odkaz:
https://doaj.org/article/4d006c066d4a45ab8b618c79c2b490fc
Autor:
Aneta Cymbaluk-Płoska, Karolina Chudecka, Anita Chudecka-Głaz, Katarzyna Piotrowska, Sebastian Kwiatkowski, Maciej Tarnowski
Publikováno v:
Diagnostics, Vol 11, Iss 6, p 1026 (2021)
Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our study, we compare a number of proteins from different effector pathways to assess their usefulness in the diagnosis of ovarian cancer. The tissue expression of th
Externí odkaz:
https://doaj.org/article/756e8cdfadf64938b2c044a7e163dd49
Autor:
Aneta Cymbaluk-Płoska, Paula Gargulińska, Michał Bulsa, Sebastian Kwiatkowski, Anita Chudecka-Głaz, Kaja Michalczyk
Publikováno v:
Diagnostics, Vol 11, Iss 4, p 626 (2021)
The aim of our research was to determine the use of CA125 and HE4 as prognostic factors in patients with different clinical staging of endometrial cancer. Sixty-two patients with advanced endometrial cancer and 287 patients with early stage endometri
Externí odkaz:
https://doaj.org/article/3f0fd74e8b794f76bcc77faaf9b545f0
Autor:
Aneta Cymbaluk-Płoska, Paula Gargulińska, Anita Chudecka-Głaz, Sebastian Kwiatkowski, Ewa Pius-Sadowska, Bogusław Machaliński
Publikováno v:
Diagnostics, Vol 10, Iss 6, p 414 (2020)
Endometrial cancer is one of the most common cancers of the reproductive organ in women. The incidence of it increases from year to year. In our study we assessed role of FGF21 and FGF23 in the diagnostics of patients with endometrial cancer. The stu
Externí odkaz:
https://doaj.org/article/a93974fe78ae4afbb762c5076173bc32
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0194270 (2018)
This study assessed the prognostic value of HE4 marker measurements at various stages of first-line chemotherapy for ovarian cancer.The study consisted of 90 ovarian cancer patients, including 48 women undergoing primary surgical treatment and 42 pat
Externí odkaz:
https://doaj.org/article/23e4c4ae64b5433cb2db040c71476b93
Autor:
Heinz Wiendl, Nicola De Stefano, Frederik Barkhof, Xavier Montalban, Anat Achiron, Tobias Derfuss, Andrew Chan, Suzanne Hodgkinson, Alexandre Prat, Letizia Leocani, Klaus Schmierer, Finn Sellebjerg, Patrick Vermersch, Hulin Jin, Elina Jarvinen, Anita Chudecka, Lidia Gardner
Publikováno v:
Monday, April 24.